Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Johnson

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonistsAn-Rong Li, Michael G Johnson, Jiwen Liu, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 9, 2023
Determining minimal clinically important difference estimates following surgery for degenerative conditions of the lumbar spine: analysis of the Canadian Spine Outcomes and Research Network (CSORN) registryJ Denise Power, Anthony V Perruccio, Mayilee Canizares, et al.
Journal of Neurosurgery. Spine|August 20, 2021
National adverse event profile after lumbar spine surgery for lumbar degenerative disorders and comparison of complication rates between hospitals: a CSORN registry studyOliver G S Ayling, Raphaele Charest-Morin, Matthew E Eagles, et al.
Journal of Neurotrauma|October 22, 2014
The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort studyMarcel F Dvorak, Vanessa K Noonan, Nader Fallah, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Journal of Neurosurgery. Spine|October 18, 2024
Gender differences in spine surgery for degenerative lumbar disease: prospective cohort studyMark A MacLean, Raphaële Charest-Morin, Alexandra Stratton, et al.
Journal of Neurosurgery. Spine|September 17, 2022
Prediction of 2-year clinical outcome trajectories in patients undergoing anterior cervical discectomy and fusion for spondylotic radiculopathyJeffrey J Hébert, Tyler Adams, Erin Cunningham, et al.
Journal of Neurotrauma|May 10, 2014
Minimizing errors in acute traumatic spinal cord injury trials by acknowledging the heterogeneity of spinal cord anatomy and injury severity: an observational Canadian cohort analysisMarcel F Dvorak, Vanessa K Noonan, Nader Fallah, et al.
Journal of Medicinal Chemistry|July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry|December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid CancersChristopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonistsAn-Rong Li, Michael G Johnson, Jiwen Liu, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 9, 2023
Determining minimal clinically important difference estimates following surgery for degenerative conditions of the lumbar spine: analysis of the Canadian Spine Outcomes and Research Network (CSORN) registryJ Denise Power, Anthony V Perruccio, Mayilee Canizares, et al.
Journal of Neurosurgery. Spine|August 20, 2021
National adverse event profile after lumbar spine surgery for lumbar degenerative disorders and comparison of complication rates between hospitals: a CSORN registry studyOliver G S Ayling, Raphaele Charest-Morin, Matthew E Eagles, et al.
Journal of Neurotrauma|October 22, 2014
The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort studyMarcel F Dvorak, Vanessa K Noonan, Nader Fallah, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Journal of Neurosurgery. Spine|October 18, 2024
Gender differences in spine surgery for degenerative lumbar disease: prospective cohort studyMark A MacLean, Raphaële Charest-Morin, Alexandra Stratton, et al.
Journal of Neurosurgery. Spine|September 17, 2022
Prediction of 2-year clinical outcome trajectories in patients undergoing anterior cervical discectomy and fusion for spondylotic radiculopathyJeffrey J Hébert, Tyler Adams, Erin Cunningham, et al.
Journal of Neurotrauma|May 10, 2014
Minimizing errors in acute traumatic spinal cord injury trials by acknowledging the heterogeneity of spinal cord anatomy and injury severity: an observational Canadian cohort analysisMarcel F Dvorak, Vanessa K Noonan, Nader Fallah, et al.
Journal of Medicinal Chemistry|July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.
Journal of Medicinal Chemistry|December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid CancersChristopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Pageof 10